Skip to content

Paravertebral Block Versus Epidural Anesthesia for Percutaneous Nephrolithotomy

Comparison of Paravertebral Block Versus Epidural Anesthesia for Surgical Anesthesia of Percutaneous Nephrolithotomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03018899
Acronym
PVB
Enrollment
50
Registered
2017-01-12
Start date
2016-09-30
Completion date
2017-07-31
Last updated
2019-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Calculi

Keywords

paravertebral block, ultrasound, percutaneous nephrolithotomy, postoperative pain

Brief summary

This prospective, randomized study is aimed to assess the efficacy and safety of paravertebral block compared to epidural anesthesia for percutaneous nephrolithotomy. The investigators suppose that paravertebral block is not inferior in controlling the perioperative pain for percutaneous nephrolithotomy compared to epidural block.

Detailed description

Background: Percutaneous nephrolithotomy (PCNL) is generally performed under general or neuraxial anesthesia. The investigators have reported three patients who were at high risk of both general anesthesia and neuraxial anesthesia received percutaneous nephrolithotomy with ultrasound guided paravertebral block. Then,The investigators performed ultrasound guided paravertebral block for 45 patients who received percutaneous nephrolithotomy successfully. The investigators' impression is that paravertebral block is as effective as epidural anesthesia for surgical anesthesia of percutaneous nephrolithotomy. Objectives:To assess the efficacy and safety of paravertebral block compared to epidural anesthesia for surgical anesthesia of percutaneous nephrolithotomy. Methods: Fifty adult patients undergoing elective percutaneous nephrolithotomy will be randomized to receive ultrasound guided paravertebral block or epidural anesthesia. The primary outcome will be the pain score 12h postoperation. The secondary outcomes will include: time spent to perform block, dose of intraoperative opioids, rate of hypotension need for vasoconstrictors, muscle Power Grading of the lower legs at the end of the operation, anus exhaust time, opioid consumption postoperation, postoperative PONV score and the frequency of vomiting , hospitalization duration and patient satisfaction. Clinical Implications: Ultrasound guided paravertebral block could be an equally effective and safe alternative to epidural block for surgical anesthesia of percutaneous nephrolithotomy.

Interventions

PROCEDUREparavertebral block

Ultrasound guided two-segment paravertebral block

PROCEDUREepidural anesthesia

thoracic epidural anesthesia

Sponsors

Huazhong University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists physical statusⅠ-Ⅲ * Undergo first stage percutaneous nephrolithotomy * Informed consent

Exclusion criteria

* BMI\>35 * Coagulopathy, on anticoagulants * History of surgery on spine * Spine deformity * A known allergy to the drugs being used * Tumor or infection at the site of puncture * inability to provide adequate informed consent * refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
pain score 12h post operation12 hours postoperation

Secondary

MeasureTime frameDescription
dose of intraoperative opioidsduring operation
rate of hypotensionduring operation
Muscle Power Grading of the lower legs at the end of the operation12 hours postoperation
time spent to perform blockduring block
postoperative PONV score and the frequency of vomiting24 hours postoperation
Hospitalization duration10 days postoperation
Patient satisfactionone day before dischargePatient satisfaction will be evaluated by 5-point Likert scal
opioid consumption postoperation12 hours postoperation

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026